Trump Demands Access to Africa’s Rare Minerals as Price to Fund Efforts to Battle AIDs

Key Takeaways

• Trump administration links PEPFAR funding to mineral access
• Zimbabwe and Zambia reject MOUs, halting aid disbursement
• Critics warn aid politicization could reverse HIV progress
• PEPFAR has saved 25 million lives since 2003

Pulse Analysis

PEPFAR, launched in 2003, has become the world’s largest single‑disease health program, delivering antiretroviral therapy to over 20 million people and preventing millions of mother‑to‑child transmissions. Its success has been built on a bipartisan consensus that health outcomes, not geopolitics, should drive funding decisions. The recent shift toward an "America First" framework repositions the program as a bargaining chip, demanding mineral concessions from partner nations in exchange for continued financial support.

The mineral demand centers on cobalt, lithium and other rare earth elements critical to U.S. clean‑energy supply chains. By conditioning aid on access to these resources, the State Department hopes to secure strategic inputs for batteries and electronics. However, Zimbabwe and Zambia’s refusal to sign the memoranda highlights the diplomatic friction such a strategy creates. Both governments argue that health assistance should remain unconditional, and the stalemate threatens to suspend millions of dollars in PEPFAR grants, jeopardizing treatment continuity for vulnerable populations.

If the United States proceeds with resource‑linked aid, it could set a precedent that other donors might follow, reshaping global health financing toward a model where aid is contingent on economic concessions. Critics warn this could erode trust, reduce program effectiveness, and ultimately reverse hard‑won gains against HIV/AIDS. Policymakers face a choice: maintain health‑centric funding that safeguards public‑health outcomes, or pursue a resource‑driven approach that risks both diplomatic relations and the lives of millions dependent on PEPFAR services.